Delivery Order SPE2DB20D2104-SPE2DB25FMGWL
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Synthroid 100 micrograms tablets in quantities of 1,000 units, with a ceiling value of $1,061.94. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is due for completion by September 16, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This...
- The Defense Logistics Agency awarded a delivery order valued at $6,931.37 to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 50 micrograms. The contract, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $3,135.68 to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Synthroid 50 microgram tablets in quantities of 1,000 units. This is a firm fixed-price delivery order with an ultimate completion date of August 13, 2025, with performance to take place at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency Medical Supply Chain awarded a $3,537.98 delivery order to AmerisourceBergen Drug Corp for 1,000 units of Synthroid 25 micrograms on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement under delivery order contract type. The award was placed to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the vendor is headquartered...
- The Defense Logistics Agency awarded a delivery order valued at $1,041.98 to AmerisourceBergen Drug Corp for the supply of Synthroid 25 microgram tablets (90-count units) on August 26, 2025, with completion expected by August 27, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,231.14 to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 50 mcg. This firm fixed-price delivery order, issued on September 17, 2025, with completion targeted for September 18, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $3,823.10 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Synthroid 125 micrograms. This competitively awarded, firm fixed-price delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Synthroid 100 microgram tablets in quantities of 1,000 units. This firm fixed-price delivery order, valued at $1,478.35, represents a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement running through December 2026. The contract involves no set-aside designation and...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of 1,000 tablets of Synthroid 137 micrograms at a ceiling value of $2,134.25. This is a firm fixed-price delivery order with no set-aside designation, completed by July 31, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award represents a competitive procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,630.09 to AmerisourceBergen Drug Corp for the supply of Synthroid 50 MCG tablets (1,000 units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside contract employs firm fixed pricing and is classified as a delivery order under the competitive procurement process. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMGWLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,163.33 to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 50 micrograms on August 6, 2025, with completion scheduled for August 7, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and running through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The smaller Synthroid order exemplifies the company's role in supplying critical medications to federal healthcare systems, with the underlying contract vehicle providing flexible capacity to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/6/25 |